Introduction {#s1}
============

Long-term potentiation (LTP) is the most intensively studied type of synaptic plasticity in the vertebrate central nervous system (CNS), driven by the widely-held view that the mechanism is engaged by, and is critical for, learning and memory processes (Bliss and Collingridge, [@B7]). LTP has been most extensively studied at the Schaffer collateral-commissural pathway, a monosynaptic connection between CA3 and CA1 pyramidal neurons of the hippocampus. The principles uncovered by studying these synapses have been generalized to many, but not all, excitatory synapses in the CNS. It is established that there are several distinct forms of LTP that co-exist over the first few hours following its induction (Park et al., [@B59]). The first to be observed is termed short-term potentiation (STP), which is triggered by high frequency stimulation (HFS) and decays in an activity-dependent manner (Volianskis and Jensen, [@B83]). Without post-induction stimulation, STP can last for, at least, many hours. STP is expressed by an increase in the probability of neurotransmitter release, P(r). Multiple, mechanistically distinct forms of LTP can also be induced, which are often termed LTP1, LTP2 and LTP3 (see Abraham and Otani, [@B1]; Bliss and Collingridge, [@B7]; Reymann and Frey, [@B67] for reviews). Here, we adopt the following nomenclature: LTP1 (also referred to as early-LTP or E-LTP) can be triggered by a single episode of HFS, such as a tetanus or theta burst stimulation (TBS) protocol. It is also commonly induced by multiple episodes of HFS or by "pairing" protocols. LTP1 can last for several hours, at least. In adult rodents, it requires activation of Ca^2+^/calmodulin-dependent protein kinase II (CaMKII) but is independent of both PKA and protein synthesis. There is considerable evidence that it is expressed by an increase in the number of AMPA receptors (AMPARs) inserted into the postsynaptic membrane. LTP2 (also referred to as late phase-LTP or L-LTP) normally requires multiple episodes of HFS (e.g., tetani or TBS) for its induction; critically these episodes need to be appropriately spaced in time, typically in the order of 10 min. Since these spaced protocols will also induce LTP1, the resulting potentiation is a composite of LTP1 and LTP2, initially at least. LTP2 can last many hours *in vitro* and, most probably, is associated with synaptic growth with corresponding pre- and postsynaptic alterations. Unlike LTP1, LTP2 requires activation of protein kinase A (PKA) and *de novo* protein synthesis, but does not involve transcription. LTP3 requires transcription and is not considered further in the present article. For a recent review of these three types of synaptic plasticity the reader is referred to Bliss et al. ([@B8]).

In terms of the induction trigger, all these forms of synaptic plasticity ordinarily require the synaptic activation of NMDA receptors (NMDARs). However, there are some differences in their NMDAR subunit dependence. LTP1 is induced primarily by the activation of triheteromeric assemblies of GluN1, GluN2A and GluN2B whereas STP has a component that requires activation of GluN2B and GluN2D (Volianskis et al., [@B84]). Since the NMDAR is subject to a highly voltage-dependent block by Mg^2+^ ions, which is transiently alleviated during HFS (Herron et al., [@B28]), the NMDAR confers Hebbian-like properties on LTP. Under certain circumstances, metabotropic glutamate receptors (mGluRs) can serve as co-triggers for the induction of NMDAR-dependent LTP (Bashir et al., [@B5]; Bortolotto et al., [@B10]), possibly by facilitating the activation of NMDARs (Tigaret et al., [@B80]).

The first suggestion that calcium-permeable (CP)-AMPARs could be triggers for LTP at CA1 synapses was the finding that, in mice engineered to lack the GluA2 subunit, LTP could be induced when NMDARs were blocked (Jia et al., [@B32]; Figures [1A,B](#F1){ref-type="fig"}). Since GluA2-lacking receptors are calcium permeable (Burnashev et al., [@B11]), this suggested that CP-AMPARs may be alternative triggers for LTP at CA1 synapses. This form of LTP probably involves a postsynaptic change in the number or conductance properties of AMPARs (Mainen et al., [@B43]). In support of the idea that CP-AMPARs can trigger LTP at these synapses, transfection of unedited GluA2 into CA1 pyramidal neurons enabled NMDAR-independent LTP to be induced (Okada et al., [@B55]).

![Calcium-permeable (CP)-AMPA receptors (AMPARs) can trigger long-term potentiation (LTP) at CA1 synapses. **(A)** Larger LTP in GluA2^−/--^ mice compared with wild-type littermates. **(B)** NMDA receptors (NMDARs)-independent LTP in the GluA2^−/--^ mice. **(C)** Acute restraint stress facilitates LTP. **(D)** Acute restraint stress enables NMDAR-independent LTP. Panels **(A,B)** from Jia et al. ([@B32]) and **(C,D)** from Whitehead et al. ([@B87]).](fnsyn-10-00042-g0001){#F1}

Interestingly, in the GluA2 KO mouse in the absence of an NMDAR antagonist, both the CP-AMPAR and NMDAR-dependent forms of LTP were additive, suggesting two distinct forms of LTP can co-exist at CA1 synapses (Jia et al., [@B32]). These pioneering experiments did not, however, address whether CP-AMPARs are engaged during synaptic plasticity in wild type animals. The lack of GluA2 results in the formation of aberrant glutamate receptor complexes involving GluA1 and GluA3 subunits as well as an increase in the number of GluA1 and GluA3 homomeric receptors (Sans et al., [@B73]). Furthermore, in both a different GluA2 global KO and in a forebrain-specific GluA2 KO, the LTP appeared normal (Shimshek et al., [@B74]), however there was enhanced STP in the conditional GluA2 KO. Therefore, the significance of CP-AMPARs as triggers for synaptic plasticity was unclear.

A clue to a physiological role for these receptors in wild type animals was the finding that inhibitors of CP-AMPARs could largely reverse LTP if applied shortly after the induction of LTP (Figure [2A](#F2){ref-type="fig"}). However, if the application of these inhibitors was delayed for 30 min or so, they were no longer effective (Figure [2B](#F2){ref-type="fig"}). The implication from these observations is that there is a short time window following the triggering of LTP where CP-AMPARs may be required for the full expression of LTP. It was also found that if baseline stimulation was paused during this same time window following the induction of LTP, then LTP was not fully expressed (Figure [2C](#F2){ref-type="fig"}). This suggested that low frequency synaptic activation of CP-AMPARs was required to fully sustain LTP. The obvious inference was that low frequency stimulation triggers Ca^2+^ entry through CP-AMPARs and that this Ca^2+^ signal is required for the full expression of LTP. However, two other labs using similar methods found no evidence for a role of CP-AMPARs in LTP at CA1 synapses (Adesnik and Nicoll, [@B2]; Gray et al., [@B23]). Another LTP controversy was brewing.

![LTP2, but not LTP1, is sensitive to CP-AMPAR blockers. **(A)** Philanthotoxin (PhTx) reverses the potentiation when applied starting 10 min after pairing-induced LTP.**(B)** PhTx has no effect when applied starting 20 min after the induction of LTP.**(C)** LTP is not induced when baseline stimulation is paused for 15 min following pairing (from Plant et al., [@B63]). **(D)** IEM 1460 (30 μM) has no effect on LTP induced by compressed protocol (cTBS; *n* = 8 and 6 for vehicle and IEM experiments, respectively). **(E)** IEM 1460 applied immediately following the first theta burst stimulation (TBS) inhibits LTP. **(F)** IEM 1460 applied 1 h following the last spaced protocol (sTBS) has no effect on LTP. **(G)** Summary data (*n* = 6--10 for IEM experiments, *n* = 21 for interleaved controls). Each graph plots the mean ± SEM normalized fEPSP slope for vehicle-treated (black) and interleaved drug-treated (color) slices. The open symbols are the corresponding control (no TBS) inputs. Representative traces (average of five successive recordings) are shown for the times indicated by numbers. \**p* \< 0.05, \*\**p* \< 0.01 and \*\*\**p* \< 0.001 vs. control. Reproduced from Park et al. ([@B58]).](fnsyn-10-00042-g0002){#F2}

The reason for these differences was not readily apparent at the time. But further evidence that CP-AMPARs can contribute, under certain circumstances, to LTP at these synapses was the finding that these receptors enabled an NMDAR-independent form of LTP following brief exposure of the animals to acute restraint stress (Whitehead et al., [@B87]). Indeed, the effect of brief stress, or exposure to glucocorticoids, resulted in a situation highly reminiscent of the GluA2 KO mouse (Figures [1C,D](#F1){ref-type="fig"}). So what was clear from these earlier studies is that CP-AMPARs can, but do not necessarily, contribute to LTP at CA1 synapses onto principal neurons. We became interested, therefore, in establishing the physiological conditions that determined whether CP-AMPARs participate in LTP at these synapses.

Pharmacological Evidence That CP-AMPARs Are Required for LTP2 but Not LTP1 {#s2}
==========================================================================

We re-investigated the role of CP-AMPARs in LTP by comparing the effect of two types of induction protocols (Park et al., [@B58]). We delivered three episodes of TBS, with each episode comprised of five bursts (each of five shocks at 100 Hz) with an inter-burst frequency of 5 Hz (total 75 stimuli). Notably, the only difference between the two interleaved protocols was the inter-episode interval. We either used a compressed protocol (cTBS) where the inter-episode interval was 10 s or a spaced protocol (sTBS) where the inter-episode interval was in the order of minutes (typically 10 or 20 min). cTBS led to an LTP that is, after STP had decayed, exclusively LTP1. In contrast, sTBS induced an LTP that was a mixture of LTP1 and LTP2. In agreement with previous work (Matthies and Reymann, [@B47]; Huang and Kandel, [@B29]), LTP1 was resistant to inhibitors of PKA while LTP2 was sensitive to these inhibitors. We found a similar differential sensitivity to inhibitors of CP-AMPARs (Figures [2D--G](#F2){ref-type="fig"}). Thus, IEM 1460 (IEM; Samoilova et al., [@B70]), philanthotoxin 433, or 1-naphthyl acetyl spermine (NASPM) had no effect on LTP induced by a cTBS (i.e., LTP1) but inhibited a component of sLTP (presumably LTP2). Consistent with the previous study (Plant et al., [@B63]), IEM was still effective if applied shortly after the TBS but not if applied 1 h following the TBS (Figures [2E--G](#F2){ref-type="fig"}), confirming a transient time window for the involvement of CP-AMPARs.

Stimulation Post TBS Is Required for LTP2 {#s3}
=========================================

Consistent with the earlier report (Plant et al., [@B63]) that stimulation is required post induction for the full expression of LTP, we observed that if we stopped stimulation following the sTBS protocol then LTP was reduced (Figure [3](#F3){ref-type="fig"}). We interpreted this result to mean that, for a short time window after the synaptic activation of NMDARs, low frequency stimulation is required to induce LTP2 and, consequently, when stimulation is paused then only LTP1 is observed. In conclusion, there exists a critical period following sTBS that requires low frequency synaptic activation and the synaptic expression of CP-AMPARs to generate the PKA- and protein synthesis-dependent form of LTP (i.e., LTP2). The simplest explanation is that low frequency stimulation drives Ca^2+^ through CP-AMPARs and that this Ca^2+^ signal is required for the *de novo* protein synthesis.

![Stimulation post-TBS is required for LTP2. **(A)** Baseline stimulation was paused following the second and third sTBS episodes (apart from an initial stimulation to assess short-term potentiation, STP) for nine experiments. **(B)** Interleaved control experiments where there was no pause in stimulation (*n* = 7). **(C)** Representative traces (at the times indicated by numbers). **(D)** Quantification of these experiments (2 h post TBS). Reproduced from Park et al. ([@B58]). \*\**p* \< 0.01 vs. control.](fnsyn-10-00042-g0003){#F3}

One difference between these observations and the previous study that revealed a role for CP-AMPARs (Plant et al., [@B63]) is in the induction protocols that were used to generate LTP. The earlier study did not use a spaced induction protocol and so, according to our recent results, should have induced only LTP1. In which case, the LTP would have been insensitive to blockers of CP-AMPARs and resistant to a pause in stimulation, just as described in two other studies (Adesnik and Nicoll, [@B2]; Gray et al., [@B23]). However, there may be metaplastic effects that can prime for LTP2. One likely factor is the level of stress that an animal experiences. As described above, a brief period of restraint stress leads to the PKA-dependent insertion of CP-AMPARs into the synaptic membrane (Whitehead et al., [@B87]). Therefore, stress may lead to the synaptic insertion of CP-AMPARs such that a spaced induction protocol is no longer required to induce LTP2. In conclusion, while stress and probably other factors that activate PKA, may prime for LTP2, a spaced induction protocol is typically required for its expression under most physiological conditions.

In conclusion, our pharmacological experiments have clearly identified two forms of LTP that co-exist at CA1 synapses that can be distinguished on the basis to their sensitivity to inhibitors of CP-AMPARs. LTP1 does not require their activation, whereas LTP2 does require CP-AMPARs. Furthermore, LTP2 requires baseline stimulation following TBS. The reports of Adesnik and Nicoll ([@B2]) and Gray et al. ([@B23]) are not inconsistent with this conclusion, since their protocols would have only induced LTP1.

Physiological Evidence That CP-AMPARs Are Required for LTP2 but Not LTP1 {#s4}
========================================================================

Rather than to rely on pharmacological evidence alone, we also probed for the synaptic insertion of CP-AMPARs by measuring synaptic AMPAR rectification. GluA2-lacking AMPARs are inwardly rectifying due to an endogenous voltage-dependent block by spermine (Donevan and Rogawski, [@B19]; Isa et al., [@B30]) and so we measured their rectification index (RI) shortly after inducing LTP (Plant et al., [@B63]; Adesnik and Nicoll, [@B2]) with cTBS and sTBS protocols. We found no change in the RI following cTBS but a significant increase in rectification following sTBS (Park et al., [@B58]). These observations are consistent with the synaptic insertion of CP-AMPARs into a background of calcium-impermeable (CI) AMPARs.

The PKA-dependent component of LTP (i.e., LTP2) can also be induced by a single episode of TBS delivered under conditions where cAMP generation is enhanced, such as in the presence of the phosphodiesterase 4 (PDE4) inhibitor rolipram (Barad et al., [@B4]). We found that the rolipram-enhanced LTP was due to the insertion of CP-AMPARs as probed either with IEM 1460 or using RI measurements (Park et al., [@B58]).

A Model for the Induction of LTP at CA1 Synapses {#s5}
================================================

The mechanism of induction of LTP is rather more complex than originally proposed (Collingridge, [@B14]). In Figure [4](#F4){ref-type="fig"}, we present a model based on our current understanding, which elaborates upon our earlier model (Park et al., [@B58]). For simplicity we have omitted STP. A compressed induction protocol (e.g., cTBS) induces only LTP1, which may involve the CaMKII-dependent insertion of more AMPARs (Hayashi et al., [@B26]; Lu et al., [@B42]; Pickard et al., [@B61]). It also primes for LTP2 by activating PKA (Frey et al., [@B21]; Matthies and Reymann, [@B47]), which drives CP-AMPARs into the perisynaptic plasma membrane, via a process involving phosphorylation of S845 of GluA1 (He et al., [@B27]). We propose that if a second TBS occurs while these CP-AMPARs are on the perisynaptic plasma membrane then they are driven into the synapse, from where they can be activated by low frequency stimulation to trigger LTP2. If, however, there is no subsequent TBS during this time window, which is of the order of minutes, then the CP-AMPARs are removed from the perisynaptic plasma membrane, presumably by endocytosis. In this model, the period of time during which the second and third TBS can elicit LTP2 is determined by the dwell time of CP-AMPARs on the plasma membrane. If the interval is too short (i.e., \< \~1 min) the CP-AMPARs would not have had time to traffic to the perisynaptic membrane. If the interval is too long (\>\~1 h) then the CP-AMPARs would have been removed from the perisynaptic membrane.

![A scheme to explain how CP-AMPARs may trigger LTP2. **(A)** Baseline conditions. The synaptic complement comprises NMDARs (predominantly GluN1/GluN2A/GluN2B) and calcium impermeable (CI)-AMPARs (note only one of each receptor type is shown for simplicity). **(B,C)** The first TBS (or cTBS, cHFS, etc.) induces LTP1 via activation of CaMKII and involves the synaptic insertion of additional CI-AMPARs. **(D)** The first TBS also drives CP-AMPARs into the perisynaptic plasma membrane, via a pathway involving protein kinase A (PKA). **(E)** Additional TBS activates NMDARs to drive CP-AMPARs from the perisynaptic to the synaptic membrane. **(F)** Baseline stimulation leads to Ca^2+^ entry via CP-AMPARs, which triggers *de novo* protein synthesis (via PI3K and MAPK). **(G)** Consequently, what follows is spine growth and the incorporation of additional CI-AMPARs. CP-AMPARs are removed from the synapse around the same time.](fnsyn-10-00042-g0004){#F4}

It should also be noted that our findings could be explained by the activation of CP-AMPARs that are already present at the synaptic membrane, rather than the need for their physical trafficking (Rozov et al., [@B69]). For example, the first TBS might phosphorylate CP-AMPARs and that this is a pre-requisite for the subsequent TBS to activate these receptors. However, we have based our model on the extensive literature that PKA drives the insertion of GluA1, via phosphorylation of S845, onto the plasma membrane (Man et al., [@B46]) from where it is trafficked from perisynaptic/extrasynaptic locations to synaptic sites (e.g., He et al., [@B27]; Makino and Malinow, [@B44]; Yang et al., [@B90]). Both models assume that CP-AMPARs are present for periods of time on the plasma membrane of dendritic spines of CA1 neurons, for which considerable evidence exists (e.g., Mattison et al., [@B48]).

The concept of the first TBS providing a priming for the subsequent TBS can be considered as a form of metaplasticity. Related to this, it has been shown that prior synaptic activity can lead to altered sensitivity to mGluR antagonists and enhanced LTP, via the activation of mGluRs (Bortolotto et al., [@B10]; Cohen et al., [@B13]). This additional form of LTP also requires *de novo* protein synthesis, and so is likely to represent LTP2 (Raymond et al., [@B66]). The priming, by the first episode of synaptic activity, is mediated by mGlu5 receptors (Bortolotto et al., [@B9]). Thus, there are different ways by which the protein synthesis machinery can be engaged to trigger LTP2.

Our new model raises several questions that require further experimentation:

1.  What are the roles of NMDARs during the induction of LTP2? Are these only required during the first, priming TBS to activate PKA or are they also required during the subsequent TBS to, for example, drive the CP-AMPARs from the perisynaptic to the synaptic membrane? The latter could, in principle, not require activation of NMDARs since CP-AMPARs can trigger LTP in an NMDAR-independent manner (Jia et al., [@B32]; Whitehead et al., [@B87]).

2.  What are the signaling mechanisms that drive CP-AMPARs from perisynaptic to synaptic sites, in response to additional bouts of TBS? There have been several suggestions, including CaMKII (Hayashi et al., [@B26]), CaMKI (Guire et al., [@B25]) and PKC (Yang et al., [@B90]).

3.  Why is low frequency stimulation (i.e., basal synaptic transmission) required during the critical time window? What seems to be the simplest explanation is that low frequency stimulation drives Ca^2+^ through CP-AMPARs and that this specific Ca^2+^ source is required for LTP2 (Morita et al., [@B51]). Certain of the downstream signaling molecules that are involved in LTP triggered by the activation of CP-AMPARs have been identified by studying NMDAR-independent LTP in the GluA2 homozygous and heterozygous KO mouse. This LTP involves postsynaptic Ca^2+^, PI3K, MAPK and protein synthesis but not, unlike LTP1, CaMKII (Asrar et al., [@B3]). On the reasonable assumption that the same signaling processes are engaged by CP-AMPARs to trigger LTP2 in wild type animals then it seems likely that one or more components of this pathway specifically require the CP-AMPAR-generated Ca^2+^ signal. NMDAR activation alone (during sTBS) is insufficient to trigger LTP2 presumably due to different spatiotemporal properties of the two Ca^2+^ sources. In other words, CP-AMPARs may elevate Ca^2+^ within a microdomain that is specifically associated with the protein synthesis machinery. Alternatively, the activation of protein synthesis may also require a more prolonged Ca^2+^ signal, provided by baseline stimulation, rather than only the brief, but intense, Ca^2+^ signals during the episodes of TBS.

4.  Why is the insertion of CP-AMPARs only transient and what does it trigger to sustain the potentiation? One may speculate that persistent insertion of CP-AMPARs could lead to neurotoxicity due to sustained synaptic Ca^2+^ entry (Noh et al., [@B53]; Dias et al., [@B18]). Since their dwell time on the plasma membrane is less than \~1 h, alternate means must sustain the potentiation. The most likely explanation is that CP-AMPARs trigger rapid synaptic growth, involving *de novo* protein synthesis, and that the enhanced synaptic response is maintained, at least in part, by the insertion of additional GluA2-containing, CI-AMPARs. Consistent with this idea, during glycine-induced LTP in cultured neurons, CP-AMPARs are necessary for spine enlargement via regulation of actin polymerization (Fortin et al., [@B20]).

5.  What are the mechanisms that limit the synaptic expression of CP-AMPARs under basal conditions and how are these regulated during sLTP? The first clue to a mechanism was the finding that over-expression of PICK1 leads to the synaptic insertion of CP-AMPARs in a PKC and CaMKII-dependent manner (Terashima et al., [@B78]). A putative mechanism involves the binding of PICK1 to GluA2 to internalize CI-AMPARs and so paving the way for the insertion of CP-AMPARs. In addition to PICK1, CP-AMPAR plasticity involves NSF (Gardner et al., [@B22]); a protein that binds GluA2 to stabilize synaptic AMPARs (Nishimune et al., [@B52]). Indeed, there is direct evidence that the switch from CP-AMPARs to CI-AMPARs following LTP involves GluA2 interactions with both NSF and GRIP/PICK1 (Yang et al., [@B90]).

    Related to this, it was shown that during glycine-induced LTP in cultured hippocampal neurons there was rapid insertion of GluA1 but not GluA2, due to PICK1 retention of GluA2 at the endosomal membrane (Jaafari et al., [@B31]). This interaction is then disrupted following the activation of CP-AMPARs enabling the insertion of CI-AMPARs. This second step in the process resembles a form of synaptic plasticity first identified at cerebellar stellate cell synapses where repetitive activation of CP-AMPARs leads to their replacement by CI-AMPARs (Liu and Cull-Candy, [@B39]), a process that also involves PICK1 (Liu and Cull-Candy, [@B40]).

6.  Why do three forms of long-lasting synaptic plasticity (STP, LTP1, LTP2) co-exist at CA1 synapses? Why STP exists is an easier topic to discuss. Since STP is expressed presynaptically (Davies et al., [@B17]), as an increase in P(r) (Volianskis and Jensen, [@B83]), its effects are additive to LTP1 and LTP2, which are expressed in part, if not exclusively, by postsynaptic alterations. Notably, STP and LTP1 differentially affect high frequency burst discharges, a major firing mode in the hippocampus. LTP scales all responses equally within a burst while STP alters the dynamic response within a burst, since it directly modulates P(r) (Volianskis et al., [@B85]). The ability of STP to store information for variable periods of time until it is erased by activity could be important for certain forms of short-term memory, where information is stored until needed and then quickly forgotten.

    With respect to LTP1 and LTP2, these could underlie distinct forms of memory that are distinguished by the duration of the information encoded. Although both LTP1 and LTP2 can persist for many hours in slices it seems likely that in the living animal LTP2 will last for considerably longer. That is to say that a compressed episode of HFS (e.g., cTBS) triggers LTP1 that does not require protein synthesis and is expressed primarily, or exclusively, by changes in the number or conductance properties of AMPARs (Benke et al., [@B6]; Davies et al., [@B17]; Malinow and Malenka, [@B45]; Collingridge et al., [@B15]). In contrast, appropriately timed multiple trains induce LTP2 that requires protein synthesis to enable changes that are much more persistent. These likely involve structural modifications affecting both pre- and post-synaptic function. Indeed, there is considerable behavioral evidence that spaced training (that may be equated to spaced LTP induction protocols) leads, via a PKA-dependent process, to more persistent memories than massed training (which may be equated to compressed LTP induction protocols; Nonaka et al., [@B54]). Accordingly, the recruitment of CP-AMPARs into synaptic plasticity processes is likely to be crucial for some, but not all, forms of NMDAR-dependent learning and memory in the hippocampus (Wiltgen et al., [@B89]). The association between CP-AMPARs and both PKA and *de novo* protein synthesis suggest that they will be involved in the laying down of more salient memories, such as those linked to fear (Clem and Huganir, [@B12]).

CP-AMPARs in Other Forms of Synaptic Plasticity at CA1 Synapses Onto Pyramidal Neurons {#s6}
======================================================================================

In addition to one type of LTP, discussed above, CP-AMPARs have also been implicated in the induction of NMDAR-dependent LTD at CA1 synapses (Sanderson et al., [@B71]). It was proposed that in LTD, the influx of Ca^2+^ through NMDARs recruits CP-AMPARs (GluA1 homomers phosphorylated on Ser845). Next, Ca^2+^ influx through both NMDARs and CP-AMPARs leads to activation of calcineurin and, in turn, to the internalization of both CP-AMPARs and CI-AMPARs, as well as spine shrinkage. This model, therefore, has several similarities to what we have proposed for LTP2. The direction of the alteration in synaptic efficacy (LTP vs. LTD) may be determined, at least in part, by the kinetics of the Ca^2+^ signals.

CP-AMPARs have also been shown to be involved in homeostatic scaling and related phenomena (e.g., Ju et al., [@B33]; Thiagarajan et al., [@B79]; Soares et al., [@B75]; Kim and Ziff, [@B35]; Kim et al., [@B34]; Sanderson et al., [@B72]). Here, the mechanisms appear to be very similar to those involved in LTP and LTD, further supporting the idea that homeostatic plasticity utilizes conventional synaptic plasticity mechanisms to provide more widespread balancing of synaptic weights.

CP-AMPARs at Other Hippocampal Synapses {#s7}
=======================================

In this review, we have focussed on the role of CP-AMPARs at synapses made between CA3 and CA1 pyramidal neurons; the pathway which has been the most intensely investigated with respect to synaptic plasticity mechanisms. However, it is worth mentioning that excitatory synapses onto many classes of inhibitory interneurons within the hippocampal formation also involve CP-AMPARs (e.g., McBain and Dingledine, [@B49]; Topolnik et al., [@B81]). At these synapses, CP-AMPARs play critical roles in synaptic plasticity (Laezza et al., [@B36]; Toth et al., [@B82]; Ross and Soltesz, [@B68]; Lei and McBain, [@B37]; Oren et al., [@B56]; Croce et al., [@B16]; Szabo et al., [@B77]). Why there is a difference between pyramidal neurons and these interneurons is not known. However, it has been suggested this may relate to their firing patterns. For example, some interneurons lack NMDAR-dependent synaptic plasticity and so can follow high frequencies of stimulation (e.g., during theta and gamma rhythms) with a stable output but remain modifiable by virtue of CP-AMPAR-dependent synaptic plasticity (Szabo et al., [@B77]).

CP-AMPARs During Development {#s8}
============================

We have focused on the role of CP-AMPARs at CA3-CA1 synapses in adult tissue. It should be pointed out, however, that early in development the situation is quite different. Whereas CP-AMPARs do not contribute to fast basal synaptic transmission in adults they participate in synaptic transmission in a subset of these synapses early in development, before around P7 (Stubblefield and Benke, [@B76]). These receptors may be removed during LTP-like activity since around this stage of development one form of LTP involves an increase in potency but a decrease in single channel conductance (Palmer et al., [@B57]); findings that are most simply explained by an exchange of high conductance CP-AMPARs for a greater number of CI-AMPARs. The idea of a subunit switch during development from CP-AMPARs to CI-AMPARs is also supported by gene expression studies (Pellegrini-Giampietro et al., [@B60]) and surface immunolabeling of cultured hippocampal neurons (Pickard et al., [@B62]).

Another study has found evidence for a role of CP-AMPARs in LTP at CA1 synapses that is developmentally regulated. In response to a single high frequency tetanus, GluA2-lacking AMPARs were required for the full expression of LTP in mice of 2-weeks and 8-weeks of age, but not in mice of 3- or 4-weeks of age (Lu et al., [@B41]). There was again a correlation between sensitivity of inhibitors of CP-AMPARs and the requirement for PKA. The protocol used in these studies is equivalent to a compressed one and would, according to our study (which was performed in rats of 3--12 weeks of age), have induced LTP that is totally independent of CP-AMPARs. However, the age of the animals used is probably relevant. We have reported previously that, in 2-week old rats, two forms of LTP can be induced by a tetanus and that one form involves a PKA-dependent mechanism (Wikström et al., [@B88]). However, why there is a re-appearance of this mechanism in 8-week old mice is less clear.

CP-AMPARs in Disease Models {#s9}
===========================

A role for CP-AMPARs in hypoxia/ischemeia is well established (e.g., Noh et al., [@B53]; Liu et al., [@B38]; Dias et al., [@B18]; Quintana et al., [@B64]). In addition, there is growing evidence for an involvement in other conditions, such as status epilepticus (Rajasekaran et al., [@B65]) and Alzheimer's disease (AD). Interestingly, a very early change in a mouse model of AD (APPswe; PS1ΔE9 transgenic mice) is an enhanced LTP which may be due to the synaptic incorporation of CP-AMPARs (Megill et al., [@B50]). Related to this, it has been shown that oligomeric Aβ (1--42) when delivered intracellularly leads to extremely rapid synaptic insertion of CP-AMPARs, via a PKA-dependent mechanism (Whitcomb et al., [@B86]). Therefore, by analogy to NMDARs (Zhou and Sheng, [@B91]), CP-AMPARs are important for normal physiological function but their expression needs to be tightly regulated to prevent neurotoxicity and other pathological conditions.

Concluding Remarks {#s10}
==================

Here we reviewed the role of CP-AMPARs in the induction of LTP at synapses onto pyramidal neurons in the hippocampus. We show that these receptors are critically involved in the PKA and protein synthesis dependent form of LTP. In addition to this role in LTP2, there is a large body of work that has identified roles of CP-AMPARs in hippocampal interneurons as well as in other forms of hippocampal synaptic plasticity. In addition, there is substantial evidence for roles of CP-AMPARs in synaptic plasticity at brain structures beyond the hippocampus, the coverage of which is outside of the scope of this review article. Clearly the field has progressed substantially since the first description of roles for CP-AMPARs in synaptic plasticity (Gu et al., [@B24]; Jia et al., [@B32]).
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